Drug Shortage Report for TEVA-FENTANYL

Last updated on 2023-10-04 History
Report ID 202265
Drug Identification Number 02282968
Brand name TEVA-FENTANYL
Common or Proper name TEVA-FENTANYL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 50MCG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 5
ATC code N02AB
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-08-17
Estimated end date 2023-09-20
Actual end date 2023-09-20
Shortage status Resolved
Updated date 2023-10-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-10-04 French Compare
v4 2023-10-04 English Compare
v3 2023-08-18 English Compare
v2 2023-08-17 French Compare
v1 2023-08-17 English Compare

Showing 1 to 5 of 5